Lastly, the prevention of the DCM phenotype of MLP KO mice by DWORF overexpression highlights the clinical potential of DWORF overexpression as a promising therapeutic for heart failure and an attractive candidate for future gene therapy studies. Here, STRIT1 is linked to familial dilated cardiomyopathy.